RecruitingNCT03822741

Etiology and Treatment of Neonatal Seizure

Gene Profiling and Individualized Treatment of Neonatal Seizure in China

Sponsor

Children's Hospital of Fudan University

Enrollment

2,000 participants

Start Date

Aug 8, 2016

Study Type

OBSERVATIONAL

Conditions

Seizures Seizure Disorder Seizure Newborn Seizure Generalized

Summary

Genetic diagnosis for neonates suffering from epilepsy has important implications for treatment, prognosis, and development of precision medicine strategies. Investigator performed exome sequencing (ES) or targeted sequencing on neonates with seizure onset within the first month of life. Investigator subgrouped our patients based on the onset age of seizure into neonatal and before 1 year (1-12 months), to compare the clinical and genetic features and treatment strategies.

Eligibility

Max Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with seizure disorder, seizure generalized, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.